AMYLASE - ANVISA Registration 10287410392
Access comprehensive regulatory information for AMYLASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287410392 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10287410392
25351196499200424
30280358000186
Company Information
Dates and Status
Dec 23, 2004
VIGENTE
09/18/2025 19:00:01
AMYLASE
AMYLASE / AMILASE
ABBOTT GMBH
10055310853
May 06, 1999
AMYLASE
AMILASE
GT LABORATORIOS SRL
80538800030
Jan 11, 2016
AMYLASE
Amilase
RANDOX LABORATORIES LTD.
80158990133
Jul 26, 2010
AMYLASE
AMILASE
GOLD ANALISA DIAGNOSTICA LTDA
80022230145
Jun 16, 2008
AMYLASE
Amilase
VYTTRA DIAGNOSTICOS S.A.
81692610164
Oct 29, 2019
AMILASE
Família Amilase Pancreática
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390304
May 05, 2025
AMILASE
Amilase Automação - Linha DT
DAILYTECH LATINO AMERICA LTDA
80657030075
Apr 07, 2025
AMILASE
FAMÍLIA AMILASE
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390280
Feb 17, 2025
AMILASE
AMYLASE SL
DAILYTECH LATINO AMERICA LTDA
80657030036
Dec 23, 2024
AMILASE
KIT ALFA - AMILASE
MEDMAX COMÉRCIO DE EQUIPAMENTOS MÉDICOS E SIMILARES LTDA ME
81313770052
Jul 08, 2024